LP412106-9
Pretomanid
Active
Description
Pretomanid is a new drug in the nitroimidazooxazine class that is effective as part of a multi-drug regimen against multidrug-resistant tuberculosis (MDR-TB). It has been studied in combination with bedaquiline and linezolid (BPaL) and bedaquiline, moxifloxacin, and pyrazinamide (BPaMZ). PMID: 30833432 As of November 2019, the BPaL regimen has been approved by the U.S. Food and Drug Administration for treating adult patients with extensively drug resistant (XDR) or treatment-intolerant or nonresponsive multidrug-resistant (MDR) pulmonary TB, and pretomanid is under review in the European Union. Source: Regenstrief LOINC
Basic Part Properties
- Part Name
- Pretomanid
- Part Display Name
- Pretomanid
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2019-11-02
- Construct for LOINC Short Name
- Pretomanid
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP412106-9 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP412106-9
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 培托马尼 Synonyms: CAS 187235-37-6 |
| it-IT | Italian (Italy) | Pretomanid |
| es-ES | Spanish (Spain) | Pretomanid |
| el-GR | Greek (Greece) | Πρετομανίδη Synonyms: Πρετομανίδη |
LOINC Copyright
Copyright © 2025 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://